Marr et al., 2023 - Google Patents
The tendon interfascicular basement membrane provides a vascular niche for CD146+ cell subpopulationsMarr et al., 2023
View HTML- Document ID
- 205297921633217251
- Author
- Marr N
- Zamboulis D
- Werling D
- Felder A
- Dudhia J
- Pitsillides A
- Thorpe C
- Publication year
- Publication venue
- Frontiers in Cell and Developmental Biology
External Links
Snippet
Introduction: The interfascicular matrix (IFM; also known as the endotenon) is critical to the mechanical adaptations and response to load in energy-storing tendons, such as the human Achilles and equine superficial digital flexor tendon (SDFT). We hypothesized that the IFM is …
- 102100006043 MCAM 0 title abstract description 160
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/067—Hepatocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Leigh et al. | Transcriptomic landscape of the blastema niche in regenerating adult axolotl limbs at single-cell resolution | |
| Brzoska et al. | Epithelial differentiation of human adipose tissue-derived adult stem cells | |
| Eghbali-Fatourechi et al. | Characterization of circulating osteoblast lineage cells in humans | |
| Sakai et al. | Exhaustion of nucleus pulposus progenitor cells with ageing and degeneration of the intervertebral disc | |
| Ozeki et al. | Synovial mesenchymal stem cells promote meniscus regeneration augmented by an autologous Achilles tendon graft in a rat partial meniscus defect model | |
| Tan et al. | Isolation, characterization and the multi‐lineage differentiation potential of rabbit bone marrow‐derived mesenchymal stem cells | |
| Pasquinelli et al. | Thoracic aortas from multiorgan donors are suitable for obtaining resident angiogenic mesenchymal stromal cells | |
| Asai et al. | Tendon progenitor cells in injured tendons have strong chondrogenic potential: the CD105-negative subpopulation induces chondrogenic degeneration | |
| Chen et al. | Location of putative stem cells in human periodontal ligament | |
| Marr et al. | The tendon interfascicular basement membrane provides a vascular niche for CD146+ cell subpopulations | |
| Zscharnack et al. | Low oxygen expansion improves subsequent chondrogenesis of ovine bone-marrow-derived mesenchymal stem cells in collagen type I hydrogel | |
| Fonseca et al. | Cell surface markers for mesenchymal stem cells related to the skeletal system: A scoping review | |
| Anderson et al. | Responses to altered oxygen tension are distinct between human stem cells of high and low chondrogenic capacity | |
| Gullo et al. | Prospective purification of a subpopulation of human synovial mesenchymal stem cells with enhanced chondro-osteogenic potency | |
| Angstmann et al. | Monitoring human mesenchymal stromal cell differentiation by electrochemical impedance sensing | |
| Feisst et al. | Characterization of mesenchymal progenitor cell populations directly derived from human dermis | |
| Ilas et al. | The osteogenic commitment of CD271+ CD56+ bone marrow stromal cells (BMSCs) in osteoarthritic femoral head bone | |
| Fang et al. | A mineralizing pool of Gli1-expressing progenitors builds the tendon enthesis and demonstrates therapeutic potential | |
| Schieker et al. | Human mesenchymal stem cells at the single‐cell level: simultaneous seven‐colour immunofluorescence | |
| Sachar et al. | Osteoblasts responses to three‐dimensional nanofibrous gelatin scaffolds | |
| CN105378066A (en) | Multicolor flow cytometry method for identifying cell populations, particularly mesenchymal stem cell populations | |
| Rakic et al. | Differences in the intrinsic chondrogenic potential of equine umbilical cord matrix and cord blood mesenchymal stromal/stem cells for cartilage regeneration | |
| Lai et al. | Reconstitution of bone-like matrix in osteogenically differentiated mesenchymal stem cell–collagen constructs: A three-dimensional in vitro model to study hematopoietic stem cell niche | |
| Suto et al. | Advantage of fat-derived CD73 positive cells from multiple human tissues, prospective isolated mesenchymal stromal cells | |
| Baroncelli et al. | Human osteoblast-derived extracellular matrix with high homology to bone proteome is osteopromotive |